Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Apple, Alibaba, Amazon, and More: Analysts Are Loving These Five Stocks on Thursday

Given that the Federal Reserve has chosen to hold interest rates steady for a few more months and the broader markets are in rally mode, it’s not surprising that various analysts on the Street are bullish on some of the market’s leading names.

In this article, we’ll take a look at some of the latest positive analyst commentary/upgrades/price hikes for Analogic Corporation (NASDAQ:ALOG), Mylan NV (NASDAQ:MYL), Apple Inc. (NASDAQ:AAPL), Alibaba Group Holding Ltd (NYSE:BABA), and, Inc. (NASDAQ:AMZN). We’ll also use the latest 13F data to see how successful hedge funds are positioned in each stock.

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see the details here).

Ellica /

Ellica /

Analogic Corporation (NASDAQ:ALOG) shares are up 1.77% today in part due to positive commentary from Brean Capital analyst Jason Wittes, who raised his target price on the stock to $100 per share from $90. Wittes thought Analogic’s fiscal fourth quarter earnings were solid, and he expects the company’s revenue to grow and margins to expand in the second half of calendar year 2016. Just for reference, Analogic reported fiscal fourth quarter earnings of $1.02 per share on revenue of $138.1 million, the latter figure being down by 10.6% year-over-year. Of the 749 hedge funds that we track which filed 13Fs for the June quarter, 11 of them owned $102.73 million of Analogic Corporation (NASDAQ:ALOG) shares at the end of June, accounting for 10.50% of the float.

Follow Analogic Corp (NASDAQ:ALOG)
Trade (NASDAQ:ALOG) Now!

Count analysts at Argus as believers in Mylan NV (NASDAQ:MYL). Although the healthcare giant is still being punished in the media and on the Hill due to its previous and controversial EpiPen price hikes, Argus analyst Jacob Kilstein thinks Mylan has fallen so much (down by 22% year-to-date when EpiPen only accounts for around 20% of its profits) that the stock now offers an attractive entry point. Although it is true that Mylan’s generic $300 EpiPen will eat into branded sales that cost twice as much, the generic will also help ward off potential competitors in the future. To Kilstein, Mylan is undervalued and is a ‘Buy’. 44 funds in our system agreed as of June 30, as they were all long Mylan NV (NASDAQ:MYL) at the end of the second quarter.

Follow Mylan Inc. (NASDAQ:MYL)
Trade (NASDAQ:MYL) Now!

On the next page, we’ll find out which analysts were giving the thumbs up to Apple, Alibaba, and Amazon, and why.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.